STADA’s Partnership With Calliditas Therapeutics

McDermott Will & Emery advised STADA Arzneimittel on the deal.STADA Arzneimittel AG closed a license agreement to register and commercialize a novel specialty drug candidate for…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now